Abstract
Buruli ulcer (BU) is a neglected, tropical infectious disease of the skin and the subcutaneous tissue caused by Mycobacterium ulcerans. This pathogen has emerged as a new species from a common ancestor with Mycobacterium marinum by acquisition of the virulence plasmid pMUM. The plasmid encodes enzymes required for the synthesis of the macrolide toxin mycolactone, which has cytotoxic and immunosuppressive activities. In advanced BU lesions, extracellular clusters of M. ulcerans reside in necrotic subcutaneous tissue and are protected from infiltrating leukocytes by the cytotoxic activity of secreted mycolactone. Several lines of evidence indicate that elements of the innate immune system eliminate in many cases the initial inoculum before bacterial clusters can form and that therefore exposure to M. ulcerans leads only in a minority of individuals to the characteristic chronic necrotizing BU lesions. It is assumed that phagocytes play a key role in early host defense against M. ulcerans. Antibodies against bacterial surface structures seem to have less potential to enhance innate immunity than TH1 cell responses. Precise innate and adaptive immune effector mechanisms leading to protective immunity are however unclear, complicating the development of effective vaccines, the most desired solution to control BU. The tuberculosis vaccine Mycobacterium bovis Bacillus Calmette–Guérin (BCG) has limited short-term protective activity against BU. Whether this effect is due to the broad antigenic cross-reactivity between M. bovis and M. ulcerans or is at least partly mediated by a non-specific enhanced responsiveness of innate immune cells to secondary stimulation, recently described as “trained immunity” or “innate immune memory” is unknown but has major implications for vaccine design. Current vaccine research and development activities are focusing on recombinant BCG, subunit vaccines with selected M. ulcerans proteins, and the neutralization of mycolactone.
Highlights
Innate immunity constitutes the first line of host defense against potentially pathogenic microbial invaders
We describe how the genetic tractability and optical transparency of zebrafish embryos have enabled a variety of elegant experimental approaches to study early M. marinum infection events in vivo
Macrophages are a key component in the innate immune response to M. marinum infection, where they inadvertently play a dual role, both containing mycobacterial growth and providing an environment where the bacilli can persist (Ramakrishnan, 2012)
Summary
Innate immunity constitutes the first line of host defense against potentially pathogenic microbial invaders. Pathogenic mycobacteria, including Mycobacterium tuberculosis and its near relative M. marinum (Stinear et al, 2008) have developed mechanisms to subvert the innate immune response. One additional important difference in the gene content of the M. marinum and M. ulcerans genomes is the repertoire of ESX secretion systems and of PE/PPE proteins. Zebrafish embryos and early swimming larvae are a powerful means to dissect innate immune responses to M. marinum, as at these early developmental stages, they rely solely on innate immune mechanisms mediated by macrophages and neutrophils, and lack the elements of adaptive immunity (Davis et al, 2002) In this paragraph, we describe how the genetic tractability and optical transparency of zebrafish embryos have enabled a variety of elegant experimental approaches to study early M. marinum infection events in vivo
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
